Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tacrolimus for Cutaneous Crohn's Disease
NCT01233570Phase 2Completed
- Sponsor
- University of Aberdeen
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus in Crohn's disease, sponsored by University of Aberdeen. Status: completed.
02
Drugs
tacrolimus
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01233570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01233570.